Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol
Open Access

Mitochondrial DNA Heteroplasmy and Its Association With Embryo Developmental Variability in Assisted Reproductive Cycles

Katarzyna Nowak^{* *}Correspondence: Katarzyna Nowak, Department of Reproductive Mitochondrial Genetics, Warsaw Institute of Biomedical Research, Warsaw, Poland, Email:

Author info »

Description

Mitochondria are essential organelles responsible for cellular energy production through oxidative phosphorylation, and their role is particularly critical during early embryonic development. In assisted reproductive cycles, the functional quality of oocytes and embryos is closely linked to mitochondrial performance, as these organelles provide the adenosine triphosphate required for cleavage divisions, chromosomal segregation, and biosynthetic activity. One important mitochondrial parameter under investigation in reproductive medicine is mitochondrial Deoxyribonucleic Acid (DNA) heteroplasmy, which refers to the coexistence of multiple mitochondrial DNA variants within a single cell or organism.

Unlike nuclear DNA, mitochondrial DNA is inherited almost exclusively from the maternal lineage. However, mitochondrial populations within oocytes may contain a mixture of normal and mutated mitochondrial genomes. This mixture, known as heteroplasmy, can vary in proportion between individual oocytes and embryos. The level of heteroplasmy is considered an important determinant of mitochondrial function, as higher proportions of mutated mitochondrial DNA may impair energy production and affect developmental competence. During oogenesis, mitochondria undergo replication and segregation processes that influence the final mitochondrial content of mature oocytes. Any disruption in these processes may lead to uneven distribution of mitochondrial genomes, resulting in variability between oocytes retrieved during assisted reproductive stimulation. This variability may contribute to differences in fertilization rates, cleavage kinetics, and blastocyst formation.

Early embryonic development is highly dependent on mitochondrial oxidative phosphorylation. As the embryo transitions from maternal transcript reliance to embryonic genome activation, energy demand increases significantly. If mitochondrial DNA heteroplasmy levels are high, electron transport chain efficiency may be reduced, leading to decreased adenosine triphosphate production and increased reactive oxygen species generation. These changes can negatively influence cell division and developmental stability. Reactive oxygen species are natural byproducts of mitochondrial metabolism, but excessive accumulation can damage cellular components, including lipids, proteins, and nucleic acids. In embryos with elevated mitochondrial DNA heteroplasmy, oxidative stress may be further amplified, creating a feedback loop that exacerbates mitochondrial dysfunction. This condition may result in developmental arrest at early cleavage stages or reduced blastocyst quality.

Maternal age is one of the strongest factors associated with increased mitochondrial DNA heteroplasmy. As oocytes age, accumulated mitochondrial mutations may reduce respiratory efficiency and increase susceptibility to oxidative damage. Women of advanced reproductive age often exhibit higher variability in mitochondrial function across their oocyte cohort, which may contribute to reduced fertility and increased aneuploidy risk. Controlled ovarian stimulation used in assisted reproductive technologies retrieves multiple oocytes with varying mitochondrial profiles. Some oocytes may contain higher proportions of functional mitochondria, while others may carry a greater burden of mutated mitochondrial DNA. This heterogeneity may explain differences in embryo developmental outcomes even when fertilization conditions are standardized.

Sperm contribution to mitochondrial function is generally minimal, as paternal mitochondria are typically degraded after fertilization. However, sperm quality may still indirectly influence mitochondrial activity through fertilization efficiency and early signaling events that trigger oocyte activation. Proper calcium signaling during fertilization is essential for initiating mitochondrial redistribution and metabolic activation in the zygote. Embryo culture conditions also influence mitochondrial performance. Oxygen concentration, nutrient composition, and temperature stability all affect mitochondrial respiration and reactive oxygen species production. Culture systems that fail to replicate physiological conditions may exacerbate mitochondrial stress in embryos with pre-existing heteroplasmy, potentially reducing developmental success rates.

Mitochondrial DNA heteroplasmy may also interact with nuclear gene expression through mitochondrial-nuclear communication pathways. Nuclear-encoded genes regulate mitochondrial replication, repair, and biogenesis. Disruption in this coordination may lead to impaired cellular metabolism and altered gene expression patterns during early embryogenesis. Advanced sequencing technologies have enabled detailed analysis of mitochondrial DNA variants at single-cell resolution. These methods allow detection of low-level heteroplasmy that was previously undetectable. Such analysis has revealed that even embryos classified as morphologically normal may contain varying degrees of mitochondrial genetic diversity, raising questions about its clinical significance.

Conclusion

Current evidence suggests that mitochondrial DNA heteroplasmy plays a meaningful role in embryo developmental variability during assisted reproductive cycles. Its influence on oxidative phosphorylation, reactive oxygen species regulation, and energy availability highlights its importance in early embryogenesis. Continued integration of mitochondrial genetics, embryology, and reproductive medicine may improve understanding of oocyte quality and contribute to more precise assessment of embryo viability in assisted conception practices.